Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Marker Therapeutics, Inc. has filed 902 SEC EDGAR filings since 03 Sep 1999

SEC filing history

Showing 451-475 of 676 matching filings.

Per page
25
Current page
19
8-K File 000-27239

FORM 8-K

Filing date
29 Aug 2016
Reporting date
26 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2016
Reporting date
25 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Aug 2016
Reporting date
25 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27239

FORM 8-K

Filing date
25 Aug 2016
Reporting date
25 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-269511

D filing

Filing date
25 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-269395

D filing

Filing date
23 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-58217

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
19 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-205757

PROSPECTUS SUPPLEMENT NO 1

Filing date
15 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-58217

SCHEDULE 13D/A

Filing date
12 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Aug 2016
Reporting date
10 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27239

8-K

Filing date
11 Aug 2016
Reporting date
10 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jul 2016
Reporting date
18 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27239

FORM 8-K

Filing date
19 Jul 2016
Reporting date
18 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27239

FORM 8-K

Filing date
15 Jul 2016
Reporting date
11 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-205757

EFFECT filing

Filing date
10 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-205757

FINAL PROSPECTUS

Filing date
10 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-205757

POST EFFECTIVE AMENDMENT NO. 2

Filing date
02 Jun 2016
Reporting date
Not listed
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27239

FORM 8-K

Filing date
25 May 2016
Reporting date
19 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-205757

POST EFFECTIVE AMENDMENT NO. 1

Filing date
12 May 2016
Reporting date
Not listed
Next action
Verify source filing
10-Q/A File 000-27239

FORM 10-Q AMENDMENT NO. 1

Filing date
14 Apr 2016
Reporting date
30 Sep 2015
Next action
Verify source filing
10-Q/A File 000-27239

FORM 10-Q AMENDMENT NO. 1

Filing date
14 Apr 2016
Reporting date
30 Jun 2015
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .